Cervical disease in women referred to colposcopy following inadequate smears.

Cytopathology

Department of Gynaecological Oncology, Leicester Royal Infirmary NHS Trust, UK.

Published: February 2000

The aim of this audit was to determine if inadequate cervical smears are associated with significant cervical pathology. Case records for 52 women with three consecutive inadequate smears referred for colposcopy to the Leicester Royal Infirmary (LRI) were retrieved. Sixteen women underwent large loop excision of the transformation zone (LLETZ) and cervical intraepithelial neoplasia (CIN) was identified in six cases. There were no cases of inadequate smears initiating the diagnosis in 100 consecutive women with invasive cervical cancer. Inadequate smears are associated with high rates of treatment for a low yield of CIN. To reduce morbidity associated with colposcopy it may be acceptable to repeat an inadequate smear after 6 months rather than arranging immediate recall.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2303.2000.00218.xDOI Listing

Publication Analysis

Top Keywords

inadequate smears
16
referred colposcopy
8
smears associated
8
inadequate
6
cervical
5
smears
5
cervical disease
4
women
4
disease women
4
women referred
4

Similar Publications

Introduction During the COVID-19 pandemic, healthcare systems implemented restrictions on in-person appointments to mitigate viral spread among healthcare workers and patients. This study assesses changes in cervical cancer screening (CCS) rates within the United States Military Health System (MHS) during this period. To date, no such data have been reported on COVID-19's effect on CCS within the MHS.

View Article and Find Full Text PDF

Background: Cervical cancer is one of the commonest female cancers in Ghana. However, it is preventable. Prevention through Human Papilloma Virus immunization and early detection by screening have their foundation in awareness and a good knowledge about the disease.

View Article and Find Full Text PDF

Assessing the accuracy and clinical utility of GPT-4O in abnormal blood cell morphology recognition.

Digit Health

November 2024

Department of Clinical Laboratory Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.

Article Synopsis
  • The study evaluated GPT-4O's ability to recognize abnormal blood cell morphology, an important aspect of hematologic diagnosis, and compared its performance to experienced hematologists.
  • GPT-4O showed a 70% accuracy rate, which was significantly lower than the 95.42% accuracy of hematologists, highlighting its limitations in clinical effectiveness.
  • While GPT-4O did well with some specific cell types, overall, it struggled with critical recognition tasks and requires improvements in its algorithms and dataset for reliable clinical application in the future.*
View Article and Find Full Text PDF

Cervical cancer is a major health concern in Nigeria, where it is one of the primary causes of cancer-related deaths among women. Despite the crucial role of radiation therapy in treating cervical cancer, many patients in Nigeria do not complete their prescribed treatment courses. This review examines the barriers contributing to this issue.

View Article and Find Full Text PDF

Background: Millions of Venezuelans have been displaced because of deteriorating socio-economic conditions in their country. We examine key domains of universal health coverage among migrant Venezuelan women in Brazil: healthcare access, care quality and financial risk protection.

Methods: We collected primary data on 2012 Venezuelan women aged 15-49 who migrated to Brazil between 2018 and 2021, in the cities of Boa Vista and Manaus, along with secondary data for Brazilian women.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!